BIOVISION Investor Conference 2013

BIOVISION, the World Life Sciences Forum today announced the appointment of the Selection Committee for the BIOVISION Investor Conference 2013 , to be held March 25-26, 2013 in Lyon (France).

The event co-organized with leading clusters Lyonbiopôle and France Biotech, in partnership with EuropaBio, will be held in conjunction with the BIOVISION’s Forum.

The BIOVISION Investor Conference will match the most promising technology start-up companies with representatives from leading cross-border venture capital, advisors and global corporate firms.

The Selection Committee is composed with top-notch international investors from 9 different countries. Roman Fleck, Principal, Index Ventures, a venture capital investment firm based in Geneva, Switzerland, will be chairing the Selection Committee.

BIOVISION Investor Conference Selection Committee

Alain

Huriez

Advent Venture Partners

Marcel

Kloosterman

DSM Venturing

Lukas

Guenther

Wellington Partners Venture Capital

Ivica

Cerina

NGN Capital

Thom

Rasche

Earlybird Venture Capital

Jesus

Martin-Garcia

Eclosion

Diego

Braguglia

VI Partners AG

Angelo

De Rosa

Medtronic Europe

Sven

Rohmann

Burrill & Company

Manus

Rogan

Fountain Health Partners

Daniel

O’Mahony

Seroba Kernel

Celia

Hart

CEA Investissements

Isabelle

de Cremoux

Seventure

Franck

Lescure

Auriga Partners

Marie-Laure

Guarrigues

CDC entreprises

François

Valencony

Merieux Developpement

Françcois

Miceli

Sofimac

Joey

Mason

Delta Partners

Ilka

Wicke

Boehringer Ingelheim Venture Fund

Maciek

Drozdz

Entrepreneurs Fund Management LLP

Mark

Redshaw

Evonik Corporate Venturing

Claus

Andersson

Sunstone Capital

Maurizio

PetitBon

Kreos Capital

Hans

Kuepper

Global Life Sciences Ventures

Christina

Takke

Forbion Capital Partners

Jasper

Bos

Merck Serono Ventures

Davide

Turco

Altante Ventures (IntesaSanPaolo)

Muriel

Bekto

LifeScan J&J

Alexandra

Goll

TVM Capital

Aris

Constandinides

NBGI Ventures

Mark

Wilson

GlaxoSmithKline Pharmaceuticals

Antoine

Papiernik

Sofinnova Partners

Gérard

Hascoet

MDStart

Renee

Aguiar-Lucander

Omega Funds

About BIOVISION
BIOVISION is organized since 1999 in Lyon by the Fondation pour l’Université de Lyon, an independent non-profit organization. BIOVISION brings together top decision-makers from the academic, private, policy-making and civil society sectors to translate innovative ideas into actionable solutions for the benefit of citizens.
The next edition of the BIOVISION World Life Sciences Forum will be held March 24-26, 2013 in Lyon (France). It expects more than 3,000 participants from 60 different countries, and 100 media representatives.  BIOVISION is the place where key stakeholders debate over the impact of the latest scientific advances on society and share a prospective vision on how to overcome health, environment and nutrition challenges.
More information on BIOVISION at www.BIOVISION.org.

Media Contact
BIOVISION, the World Life Sciences Forum
Souad Gara, Communications Director
Phone: (33) 4 78 92 70 19
Mobile: (33) 6 20 51 68 37
E-mail: souad.gara@biovision.org

Leave a Reply